Related Experiment Video
Updated: Feb 6, 2026

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial
Sangiliyandi Gurunathan1, Min-Hee Kang2, Jin-Hoi Kim3
1Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul 05029, Korea. gsangiliyandi@yahoo.com.
Abstract:
Although many treatment strategies have been reported for lung disease, the mechanism of combination therapy using silver nanoparticles (AgNPs) and histone deacetylases inhibitors (HDACi) remains unclear. Therefore, innovative treatment strategies are essential for addressing the therapeutic challenges of this highly aggressive lung cancer. AgNPs and HDACi seem to be the best candidates for anticancer therapy because of their anti-proliferative effect in a variety of cancer cells. First, we synthesized AgNPs using wogonin as a reducing and stabilizing agent, following which the synthesized AgNPs were characterized by various analytical techniques. The synthesized AgNPs exhibited dose- and size-dependent toxicity towards A549 cells. Interestingly, the combination of AgNPs and MS-275 significantly induces apoptosis, which was accompanied by an increased level of reactive oxygen species (ROS); leakage of lactate dehydrogenase (LDH); secretion of TNFα; dysfunction of mitochondria; accumulation autophagosomes; caspase 9/3 activation; up and down regulation of pro-apoptotic genes and anti-apoptotic genes, respectively; and eventually, induced DNA-fragmentation. Our findings suggest that AgNPs and MS-275 induce cell death in A549 lung cells via the mitochondrial-mediated intrinsic apoptotic pathway. Finally, our data show that the combination of AgNPs and MS-275 is a promising new approach for the treatment of lung cancer and our findings contribute to understanding the potential roles of AgNPs and MS-275 in pulmonary disease. However, further study is warranted to potentiate the use of this combination therapy in cancer therapy trials.
Insights
This study shows that combining silver nanoparticles (AgNPs) with MS-275, a histone deacetylase inhibitor (HDACi), effectively triggers cancer cell death. This novel lung cancer treatment strategy induces apoptosis through the intrinsic pathway.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Lung cancer treatment faces challenges due to its aggressive nature.
- Combination therapies with silver nanoparticles (AgNPs) and histone deacetylase inhibitors (HDACi) show promise but require mechanistic understanding.
Purpose of the Study:
- To investigate the mechanism of combined AgNPs and HDACi (MS-275) therapy in lung cancer.
- To evaluate the efficacy of AgNPs synthesized using wogonin in combination with MS-275 against A549 lung cancer cells.
Main Methods:
- Synthesis and characterization of AgNPs using wogonin.
- Assessment of AgNP toxicity on A549 cells.
- Evaluation of combined AgNPs and MS-275 effects on apoptosis, reactive oxygen species (ROS), lactate dehydrogenase (LDH) release, TNFα secretion, mitochondrial function, and gene expression.
Main Results:
- Synthesized AgNPs demonstrated dose- and size-dependent toxicity to A549 cells.
- The combination of AgNPs and MS-275 significantly induced apoptosis via the mitochondrial-mediated intrinsic pathway.
- Key indicators of apoptosis, including ROS generation, LDH leakage, TNFα secretion, caspase activation, and DNA fragmentation, were observed.
Conclusions:
- The combination of AgNPs and MS-275 represents a promising therapeutic strategy for lung cancer.
- This combination induces lung cancer cell death through the intrinsic apoptotic pathway.
- Further research is warranted to advance this combination therapy towards clinical application.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Histone Variants at the Centromere
Alveoli and Alveolar Ducts
Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...

